Thomas Miller
SVP, Head of Research Walden Biosciences
Seminars
Thursday 20th August 2026
Targeting Undruggable Targets: Advancing Kidney-Targeted Therapies Through Molecular Engineering to Overcome Tissue Targeting Barriers
2:30 pm
- Applying molecular engineering approaches to address “undruggable” targets
- Addressing barriers to renal tissue targeting
- Targeting dysregulated/diseased cells to restore renal function
